USPTO announced COVID-19 prioritization program

The United States Patent and Trademark Office (USPTO) announced that it will accept petitions to advance the initial examination of applications for marks used to identify qualifying COVID-19 medical products and services. The USPTO also waived the fee for these petitions. The aim is to fast track medical products and services through the patent and trademark procedures.


Share on FacebookTweetShare